These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 7629493

  • 1. Hybrid resistance and the Ly-49 family of natural killer cell receptors.
    Yokoyama WM.
    J Exp Med; 1995 Aug 01; 182(2):273-7. PubMed ID: 7629493
    [No Abstract] [Full Text] [Related]

  • 2. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
    Held W, Cado D, Raulet DH.
    J Exp Med; 1996 Nov 01; 184(5):2037-41. PubMed ID: 8920892
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.
    Raziuddin A, Bennett M, Winkler-Pickett R, Ortaldo JR, Longo DL, Murphy WJ.
    Blood; 2000 Jun 15; 95(12):3840-4. PubMed ID: 10845918
    [Abstract] [Full Text] [Related]

  • 4. Toward a quantitative analysis of the repertoire of class I MHC-specific inhibitory receptors on natural killer cells.
    Vance RE, Raulet DH.
    Curr Top Microbiol Immunol; 1998 Jun 15; 230():135-60. PubMed ID: 9586355
    [No Abstract] [Full Text] [Related]

  • 5. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.
    Wang JW, Howson JM, Ghansah T, Desponts C, Ninos JM, May SL, Nguyen KH, Toyama-Sorimachi N, Kerr WG.
    Science; 2002 Mar 15; 295(5562):2094-7. PubMed ID: 11896280
    [Abstract] [Full Text] [Related]

  • 6. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.
    Raziuddin A, Longo DL, Mason L, Ortaldo JR, Murphy WJ.
    Int Immunol; 1996 Dec 15; 8(12):1833-9. PubMed ID: 8982767
    [Abstract] [Full Text] [Related]

  • 7. Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules.
    Held W, Chalifour A, Coudert JD.
    Med Microbiol Immunol; 2005 Aug 15; 194(4):169-74. PubMed ID: 15660246
    [No Abstract] [Full Text] [Related]

  • 8. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A, Longo DL, Mason L, Ortaldo JR, Bennett M, Murphy WJ.
    J Immunol; 1998 Jan 01; 160(1):87-94. PubMed ID: 9551959
    [Abstract] [Full Text] [Related]

  • 9. MHC class I recognition by Ly49 natural killer cell receptors.
    Natarajan K, Dimasi N, Wang J, Margulies DH, Mariuzza RA.
    Mol Immunol; 2002 May 01; 38(14):1023-7. PubMed ID: 11955594
    [Abstract] [Full Text] [Related]

  • 10. Fetal and neonatal NK1.1+ Ly-49- cells can distinguish between major histocompatibility complex class I(hi) and class I(lo) target cells: evidence for a Ly-49-independent negative signaling receptor.
    Sivakumar PV, Bennett M, Kumar V.
    Eur J Immunol; 1997 Dec 01; 27(12):3100-4. PubMed ID: 9464793
    [Abstract] [Full Text] [Related]

  • 11. Ly-49-independent inhibition of natural killer cell-mediated cytotoxicity by a soluble major histocompatibility complex class I molecule.
    Roth C, Kourilsky P, Ojcius DM.
    Eur J Immunol; 1994 Sep 01; 24(9):2110-4. PubMed ID: 8088332
    [Abstract] [Full Text] [Related]

  • 12. Ly-49 receptor expression and functional analysis in multiple mouse strains.
    Ortaldo JR, Mason AT, Winkler-Pickett R, Raziuddin A, Murphy WJ, Mason LH.
    J Leukoc Biol; 1999 Sep 01; 66(3):512-20. PubMed ID: 10496323
    [Abstract] [Full Text] [Related]

  • 13. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants.
    Liu J, Morris MA, Nguyen P, George TC, Koulich E, Lai WC, Schatzle JD, Kumar V, Bennett M.
    J Immunol; 2000 Feb 15; 164(4):1793-9. PubMed ID: 10657626
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vital involvement of a natural killer cell activation receptor in resistance to viral infection.
    Brown MG, Dokun AO, Heusel JW, Smith HR, Beckman DL, Blattenberger EA, Dubbelde CE, Stone LR, Scalzo AA, Yokoyama WM.
    Science; 2001 May 04; 292(5518):934-7. PubMed ID: 11340207
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ontogeny and differentiation of murine natural killer cells and their receptors.
    Sivakumar PV, Puzanov I, Williams NS, Bennett M, Kumar V.
    Curr Top Microbiol Immunol; 1998 May 04; 230():161-90. PubMed ID: 9586356
    [No Abstract] [Full Text] [Related]

  • 18. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens.
    Raziuddin A, Longo DL, Bennett M, Winkler-Pickett R, Ortaldo JR, Murphy WJ.
    Blood; 2002 Oct 15; 100(8):3026-33. PubMed ID: 12351417
    [Abstract] [Full Text] [Related]

  • 19. NK cell tolerance: revisiting the central dogma.
    MacDonald HR.
    Nat Immunol; 2005 Sep 15; 6(9):868-9. PubMed ID: 16116465
    [No Abstract] [Full Text] [Related]

  • 20. Activation of natural killer cells: underlying molecular mechanisms revealed.
    Backström E, Kristensson K, Ljunggren HG.
    Scand J Immunol; 2004 Sep 15; 60(1-2):14-22. PubMed ID: 15238069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.